ABVX three-lens brief
Evidence-based stock research on ABVX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.94% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -2.94% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $165.91 — 43% above current (11 analysts).
- Negative free cash flow last quarterly (-$114.47M).
ABVX closed at $115.95 (-2.94%) as of 2026-09-11. Market cap: $10.12B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $165.91 — 43% above current (11 analysts).. Concerns: moved -2.94% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $1.30M, net income -$48.50M, free cash flow -$114.47M. Watching for: 2026-09-21 earnings release (10 days out).
Why three lenses on ABVX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ABVXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ABVX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ABVX brief"></iframe>